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Summary
Background: External application of clay facial masks is a 
cosmetic procedure generally used to reduce skin lesions 
and to improve overall skin condition. Objective: Collecting 
pilot data about self-treatment with clay jojoba oil masks on 
participants with acne-prone, lesioned skin and acne. Meth-
ods: Open, prospective, observational pilot study: Partici-
pants received written information, instructions, and ques-
tionnaires without direct contact with the study physician. 
For 6 weeks, they applied the masks 2–3 times per week. 
The primary outcome is the difference of skin lesions: base-
line vs. after 6 weeks. Results: 194 participants (192 female, 
2 male, mean age (± SE) (32.3 ± 0.7 years) returned ques-
tionnaires and diaries. 133 of these participants returned 
complete and precise lesion counts (per-protocol (PP) col-
lective). A 54% mean reduction in total lesion count was 
 observed after 6 weeks of treatment with clay facial mask. 
Both inflammatory and non-inflammatory skin lesions were 
reduced significantly after treatment compared to baseline: 
Median counts (MC) of pustules per affected participant 
were reduced from 7.0 ± 0.9 to 3.0 ± 0.5 (mean individual 
reduction (MIR) = 49.4%), the MC of the papules from 3.5 ± 
2.2 to 1.0 ± 0.4 (MIR = 57.3%), the MC of cysts from 2.0 ± 0.8 
to 0.5 ± 0.4 (MIR = 68.6%) and the MC of comedones from 
26.5 ± 6.3 to 16.0 ± 4.0 (MIR = 39.1%). DLQI-average score 
decreased from 5.0 ± 4.5 (mean ± SE) before to 2.1 ± 2.8 
after treatment. Conclusions: The present study gives pre-
liminary evidence that healing clay jojoba oil facial masks 
can be effective treatment for lesioned skin and mild acne 
vulgaris.
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Zusammenfassung
Hintergrund: Die externe Anwendung von Heilerde-Ge-
sichtsmasken ist ein kosmetisches Verfahren, das in der 
Regel verwendet wird, um Hauteffloreszenzen zu reduzieren 
und das gesamte Hautbild zu verbessern. Ziel: Erfassen pri-
märer Daten über die Selbstbehandlung mit Heilerde-Ge-
sichtsmasken mit Jojobaöl bei Teilnehmern mit unreiner 
Haut, Hauteffloreszenzen und Akne. Methoden: Offene, pro-
spektive, empirische Pilotstudie: Die Teilnehmer erhielten 
schriftliche Informationen, Anleitungen und Fragebögen 
ohne direkten Kontakt zum Prüfarzt. 6 Wochen lang haben 
die Teilnehmer die Masken zwei- bis dreimal pro Woche an-
gewendet. Der primäre Zielparameter ist die Differenz von 
Hauteffloreszenzen: Baseline gegenüber nach 6 Wochen. 
 Ergebnisse: 194 Teilnehmer (192 weiblich, 2 männlich, mitt-
leres Alter (? Standardfehler) (32,3 ? 0,7 Jahre) haben die 
Fragebögen und Tagebücher zurückgeschickt. 133 dieser 
Teilnehmern haben die Hauteffloreszenzen vollständig und 
sehr präzise dokumentiert (Per-Protokoll(PP)-Kollektiv). Eine 
54%ige mittlere Reduktion der gesamten Effloreszenzen 
wurde nach 6 Wochen der Behandlung mit der Heilerde-
Gesichtsmaske beobachtet. Im Vergleich zur Baseline ging 
sowohl die Anzahl der entzündlichen als auch die der nicht-
entzündlichen Effloreszenzen signifikant zurück: der Median 
(M) für Pusteln pro betroffenen Teilnehmer wurde von 7,0 ? 
0,9 auf 3,0 ? 0,5 reduziert (mittlere individuelle Reduktion 
(MIR) = 49,4%), der M für Papeln von 3,5 ? 2,2 auf 1,0 ? 0,4 
(MIR = 57,3%), der M für Zysten von 2,0 ? 0,8 auf 0,5 ? 0,4 
(MIR = 68,6%) und der M für Komedonen von 26,5 ? 6,3 auf 
16,0 ? 4,0 (MIR = 39,1%). Der DLQI-Score sank von 5,0 ± 4,5 
vor der Behandlung auf 2,1 ± 2,8 nach der Behandlung. 
Schlussfolgerungen: Die vorliegende Studie gibt erste 
 Hinweise über die mögliche Wirksamkeit von Heilerde- 
Gesichtsmasken mit Jojobaöl bei der Behandlung unreiner 
Haut und milder Akne vulgaris.
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bowel syndrome [15] (internal use). The healing clay comes 
from distinct regions in Germany.
Ready-to-use facial mask with healing clay and jojoba oil is 
recommended for oily, acne-prone, and lesioned skin. The 
benefits of clay masks come mainly from their drying effects. 
This produces a substantial absorptive effect, which triggers a 
flow of fluid from the inside outwards. This flow transports 
metabolic products, cellular particles and bacterial toxins 
away from the skin and causes them to bind to the healing 
clay (‘detoxification’). The fine clay particles absorb excessive 
Introduction 
Acne-prone, lesioned skin is the result of excessive sebum 
production, bacterial settlement and inflammation. Dilated 
pores, oily and uneven skin and inflammatory and non- 
inflammatory skin lesions are characteristic for lesioned skin 
and acne [1]. Acne is one of the most common dermatologic 
diseases and is generally present in adolescent patients [2]. 
However, epidemiological studies have shown that a signi-
ficant population of female patients > 25 years old have acne, 
and this number has increased over the past 10 years [3]. A 
community-based UK study estimated the prevalence of  facial 
acne to be 14% in women between the ages of 26 and 44 years 
[4]. There are a lot of acne grading systems. In this pilot study 
we used the classification by Plewig and Kligman [2]. Causes 
for lesioned skin and other acne-like conditions in post-ado-
lescent patients may come from metabolic and hormonal im-
balances, endocrine abnormalities, use of cosmetics, nicotine, 
infections and immunological diseases [5, 6].
The conventional therapy includes topical and systemic 
retinoids, antibiotics and anti-androgens depending on sever-
ity [7]. Frequently used complementary and alternative treat-
ment methods include jojoba wax, green tea, tea tree oil, etc. 
[8–10]. Light therapy may also reduce skin lesions [11, 12]. 
The medical clay consists of fine mineral particles and trace 
elements that have both adsorptive and absorptive properties. 
Organic and inorganic substances are easily bound by hydro-
gen bonds and Van der Waals forces. Healing clay can be 
used both internally and externally. It is an effective treat-
ment for knee osteoarthritis [13], dermatological problems 
(external use) [14] and constipation-predominant irritable 
Fig. 1. Differentia-
tion and skin lesions 
counts (CRF). The 
face fielded in five 
 locations. The borders 
on the face are delin-
eated by the hairline, 
jawline, and ears. 
After skin lesion dif-
ferentiation and 
counting, the partici-
pants were asked to 
register the findings 
in there CRFs before 
the first intervention 
and after the last one.
Participants ITT (n = 194) PP (n = 133)
mean range SE mean range SE
Age, years 32.3 17–60 0.7 31.4 18–60 0.8
Height, m 1.7 1.5–1.9 0.01 1.69 1.5–1.9 0.01
Weight, kg 66.4 44–110 0.9 66.5 44–110 1.0
Body mass index, kg/m² 23.3 14.5–39.8 0.3 23.2 16.7–39.2 0.3
Mean duration of lesioned skin, years 15.8 1–46 0.7 14.7 1–46 0.8
Table 1. Patient 
characteristics
Numbers Comedonal acne Papulopustular acne Lesioned skin (≤5 skin lesions 
per half of face)
Absolute 40 66 27
Relative (%) 30.1 49.6 20.3
Comedonal acne Papulopustular acne
grade grade
I II III IV I II III IV
Absolute 12  5 7 6 44 14 4 4
Relative (%)  9.0 11.3 5.3 4.5 33.1 10.5 3 3
Table 2. Acne classi-
fication (Plewig and 
Kligman) according 
to self-reported data 
(n = 133)
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Fig. 3. Skin condition in % (baseline vs. end).
amounts of sebum, clean the pores and remove impurities 
from the skin [16–18]. Blood flow is enhanced, and supply of 
oxygen and nutrients to the skin is improved [19]. In addition, 
jojoba oil Simmondsia chinensis, an ingredient in the clay fa-
cial mask, has anti-inflammatory and antibacterial effects and 
is effective in the treatment of acne in previous studies [8]. 
However, some studies of clay/mud for dermatological prob-
lems have shown significant corelation between clay masks 
and acne and thermal mud baths and seborrheic dermatitis 
[20, 21].
We aimed to generate pilot data of the effectiveness on 
clay jojoba oil mask therapy under daily life condition. 
Methods
In order to generate the pilot data about clay jojoba oil masks in acne-
prone and lesioned skin, we performed a prospective pilot study. Parti-
cipants received written information and instructions and were asked to 
complete questionnaires and document symptoms. Study materials (clay 
jojoba oil masks which were available on the market, questionnaires, in-
structions) were distributed by mail to 200 interested participants who re-
sponded to an article in a health journal. In addition, we asked for medical 
history information in our questionnaires. As no contraindications are 
known for clay treatment no specific exclusion criteria had to be defined.
Fig. 2. Skin lesion counts by skin lesion type (median at baseline vs. end).
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The treatment consisted of a series of mask applications over 6 weeks. 
Participants were asked to apply the mask 2–3 times a week all over their 
face sparing the eye and mouth areas and to remove it after 15–20 min 
with water or a soft facial tissue. The participants were asked to count and 
to type their skin lesions. They received the instructions about skin le-
sions/differentiation [22] and skin lesion counting (fig. 1).
Additional questions asked participants about demographics, general 
well-being, history and aetiology of skin conditions, and other diseases. 
We also used the Dermatology Life Quality Index questionnaire (DLQI) 
to evaluate the impact of skin diseases on different aspects of their life 
[24]. Data were analysed descriptively. T-test was used and paired if 
 appropriate. The primary outcome measure was change in skin lesion 
counts: baseline versus the end of the treatment period (6 weeks). Further 
predefined outcome measure was quality of life score (DLQI) before and 
after treatment, number of mask applications and skin condition. We re-
ceived written informed consent for using pseudonymised data for statis-
tical evaluations from all participations. 
Results
Out of 200 mailings, questionnaires from 194 participants 
(mean age 32.4 ± 0.7 years) were returned. A completed diary 
was obtained from 194 participants. Of these 194 question-
naires, 133 were fully completed and could be entered into 
statistical analysis. Mean duration of lesioned skin was 15.8 
years. 70% of participants were non-smokers. The self-re-
ported causes for skin lesions were psychosocial stress 78.4%, 
chocolate 38.1%, solar irritation 13.4%, normonal contracep-
tives 12.9% and chemical agents 9.3%. The application of the 
clay mask was easy to handle for most participants. 133 par-
ticipants returned completed counts of their skin lesions. We 
focussed our analysis on this per-protocol (PP) collective of 
participants. There was no relevant difference in demographic 
data between the PP collective and the intention-to-treat 
(ITT) collective as shown in table 1. According to lesion 
counts, 79.8% of the PP participants could be classified as 
having acne, most of them with grade I papulopustular acne 
according to Plewig and Kligman(table 2).
43.6% of the PP collective reported having one or more con-
comitant or prior dermatologic diagnoses: 35.3% – acne vul-
garis, 6.0% – other skin diseases such as rosacea or atopic der-
matitis, and 2.3% – both acne and other dermatologic diseases. 
Of the 133 PP participants (i.e. those who counted lesions 
precisely) both inflammatory and non-inflammatory skin le-
sions were reduced significantly after treatment compared to 
baseline as can be seen in figure 2 and table 3. A 54% (PP col-
lective) mean reduction in total lesion count was observed 
after 6 weeks of treatment with clay facial mask. Average 
score of the DLQI decreased from 4.0 ± 0.4 (M ± SE) before 
treatment to 1.0 ± 0.2 after treatment. Almost all participants 
reported complying with a mean application of 2.4 times per 
week. The mean duration of the mask application was 15.6 
min, slightly longer than of the recommended 10–15 min. 
13.5% of participants reported difficulties with the application 
of the mask. 67.7% washed the mask off with water, and 
28.6% peeled off the dried mask without water. Skin feeling 
was rated ‘good’ on average during applications (M = 2.3; 1–5 
Likert scale, 1 = very good to 5 = very bad) as well as after-
wards (M = 2.0). Skin dryness (xerosis) did not change signifi-
cantly during the course of the study, but general skin condi-
tion improved significantly (fig. 3). Accordingly, about 80% 
of the participants (n = 194) rated skin sensation and effec-
tiveness of the mask as good or very good. 
Discussion
Results of this study show that treatment with clay jojoba oil 
facial masks can reduce pustules, papules, cysts, and come-
dones as well as the impact of dermatological conditions on 
quality of life. These results are consistent with studies of con-
ventional therapies such as oral and topical antibiotics [25, 
26]. The pilot study is a pragmatic, cost-effective study design 
for collecting preliminary data about self-treatments. How-
ever, these study results are limited by design and quality. The 
participants had to type and count the skin lesion by them-
selves. There were a lot of misunderstandings in interpreta-
tion of the returned lesion-count-diaries, what has contributed 
to increase in dropout rate. In conclusion, the present study 
gives preliminary evidence that healing clay jojoba oil facial 
masks can be an effective treatment for lesioned skin and 
mild acne vulgaris.
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